Indication
Post-Acute Sequelae of COVID-19
4 clinical trials
4 products
2 drugs
Clinical trial
REcovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine (RECLAIM)Status: Recruiting, Estimated PCD: 2025-05-01
Drug
IbudilastProduct
PentoxifyllineClinical trial
Phase 2a Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Larazotide (AT1001) for the Treatment of Long COVID in Children and Young AdultsStatus: Recruiting, Estimated PCD: 2025-03-31
Product
LarazotideDrug
VarlilumabClinical trial
Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2 (PASC)Status: Active (not recruiting), Estimated PCD: 2023-06-15
Product
Stellate Ganglion BlockClinical trial
Placebo-Controlled, Randomized Trial of Ensitrelvir (S-217622) for Viral Persistence and Inflammation in People Experiencing Long COVID (PREVAIL-LC)Status: Recruiting, Estimated PCD: 2025-03-31
Product
Ensitrelvir